Baker, PharmD, FCCP, FACC, FHFSA, Clinical Professor, University of Connecticut School of Pharmacy, Storrs, CT Devra Dang, PharmD, CDCES, FNAP, Clinical Professor, University of Connecticut School of Pharmacy, Storrs, CT Michael White, PharmD, FCP, FCCP, FASHP, Distinguished Professor and Chair, Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT Kelsey Giara, PharmD, University of Connecticut School of Pharmacy, Storrs, CT Kristin Waters, PharmD, BCPS, BCPP, Assistant Clinical Professor, University of Connecticut School of Pharmacy, Storrs, CT Jeff Aeschlimann, PharmD, University of Connecticut School of Pharmacy, Storrs, CT Faculty Disclosure In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity

Available from: Accessed 1 Mar 2023 Brown E, Heerspink HJL, Cuthbertson DJ, Wilding JPH (2021) SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
Compounding refers to custom-made medications prepared by specialized pharmacies rather than standardized FDA-approved drugs [9]
Some adults may qualify with a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related health condition
In a single study of 40 healthy adults, supplementation with oral Glutathione did not affect antioxidant concentration in the blood or significantly impact oxidative stress biomarkers
Clinical Perspective The panel concluded that the benefits of GLP-1RAs far outweigh potential ocular risks, given their proven: ~11.5 % HbA1c reduction 515 % weight loss (SURPASS & STEP programs) ~1426 % relative risk reduction in major CV events Hence, appropriate screening, not avoidance, should guide practice